Federation des caisses Desjardins du Quebec Trims Position in UnitedHealth Group Incorporated $UNH

Key Points

• Federation des caisses Desjardins du Quebec reduced its stake in UnitedHealth Group by 8.1%, owning 219,484 shares worth approximately $114.97 million after selling 19,263 shares in the first quarter.
• UnitedHealth Group's recent financial results showed an earnings per share (EPS) of $4.08, missing analyst estimates, with a year-over-year revenue increase of 12.9%.
• The company has declared a quarterly dividend of $2.21 per share, resulting in an annualized dividend yield of 2.9%.

Federation des caisses Desjardins du Quebec cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 219,484 shares of the healthcare conglomerate's stock after selling 19,263 shares during the period. Federation des caisses Desjardins du Quebec's holdings in UnitedHealth Group were worth $114,965,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Bayforest Capital Ltd increased its stake in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd grew its stake in UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after purchasing an additional 50 shares during the period. Copia Wealth Management purchased a new stake in UnitedHealth Group in the fourth quarter worth $42,000. IAG Wealth Partners LLC purchased a new stake in UnitedHealth Group in the first quarter worth $42,000. Finally, Investment Management Corp VA ADV purchased a new stake in UnitedHealth Group in the fourth quarter worth $44,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $309.77 on Tuesday. The stock has a 50 day moving average price of $288.34 and a 200-day moving average price of $378.14. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market cap of $280.55 billion, a price-to-earnings ratio of 13.42, a price-to-earnings-growth ratio of 2.00 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the previous year, the firm earned $6.80 EPS. UnitedHealth Group's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio is currently 38.30%.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on UNH. Bank of America upped their price target on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research note on Monday, August 18th. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Raymond James Financial downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Morgan Stanley reduced their price target on UnitedHealth Group from $342.00 to $325.00 and set an "overweight" rating for the company in a report on Wednesday, August 20th. Finally, Wolfe Research dropped their price objective on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. Fifteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus target price of $353.00.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.28% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.